Home / Going-concern warnings / AVAI BIO, INC.
Filed 2025-07-08 路 Form 10-K 路 Accession 0001740797-25-000038 micro
Price before filing: $0.5296 (2025-07-07 close, split/dividend-adjusted)
Market cap at flag: $77.9M (2025-07-08) 路 Latest: $17.5M (2026-10-16)
| Window | AVAI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +3.2% | +1.9% | +1.4% | 2025-08-07 |
| 90 days | -36.7% | +8.5% | -45.2% | 2025-10-06 |
| 180 days | -13.7% | +11.4% | -25.1% | 2026-01-05 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"These factors as discussed in Note 2 of the financial statements raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: independent auditor report in Form 10-K (period 2025-03-31)
Why this score: in auditor's report
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.